Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Non-Current Liabilities (2016 - 2025)

Prestige Consumer Healthcare has reported Other Non-Current Liabilities over the past 13 years, most recently at $5.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 14.28% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.7 million, up 14.28%, while the annual FY2025 figure was $5.4 million, 41.31% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $5.7 million at Prestige Consumer Healthcare, up from $5.4 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $9.2 million in Q1 2024 and troughed at $5.0 million in Q4 2024.
  • A 5-year average of $7.4 million and a median of $8.3 million in 2021 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 66.15% in 2021 and later rose 14.28% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $8.4 million in 2021, then increased by 5.21% to $8.9 million in 2022, then increased by 0.53% to $8.9 million in 2023, then crashed by 43.61% to $5.0 million in 2024, then rose by 14.28% to $5.7 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for PBH at $5.7 million in Q4 2025, $5.4 million in Q3 2025, and $5.4 million in Q2 2025.